News
Dechema colloquium „Games of tag – Letting protein modifications out of the lab“
18.10.2016 / For its very first edition, held at the innovative biomedical Campus Berlin-Buch, the DECHEMA colloquium will focus on protein modifications and their significant role in the development of new forms of therapy and diagnosis. We are proud to announce that Alfred Goldberg from the Harvard Medical School will give a keynote lecture on proteasome regulation, with a focus on connecting our understanding of mechanisms to disease therapies. Further fascinating presentations will address the role of protein modifications in signal transduction, protein stability, their usage in Captured Compound Mass Spectrometry, and innovative technologies for protein labeling, glycooptimisation and multimerization.
Cartoon: Russ Hodge.
Program
|
1.30 pm |
Registration open |
|
|
Chair: Thomas Sommer, Max Delbrück Center for Molecular Medicine in the Helmholtz Association |
|
2.00 pm |
Welcome to the Berlin-Buch campus Martin Lohse, Chairman of the Board of Directors and Scientific Director of the Max Delbrück Center for Molecular Medicine in the Helmholtz Association |
|
2.15 pm |
Keynote Lecture From Understanding Protein Degradation to Disease Therapy: From Cancer, and Neurodegenerative Disease to Tuberculosis Alfred L. Goldberg, Department of Cell Biology, Havard Medical School |
|
3.10 pm |
Chemical biology of Ubiquitin-mediated signal transduction Huib Ovaa, Leiden University Medical Center, Department of Chemical Immunology |
|
3.35 pm |
GlycoExpress™ – A superior platform for the production of biopharmaceuticals Lars Stöckl, Director, Glycoprotein Development and PTM Analytics, Glycotope GmbH
|
|
4.00 pm |
Coffee Break |
|
4.20 pm |
Tub-tag labeling: A novel efficient and versatile tool for the C-terminal labeling of proteins Dominik Schumacher, Chemical Biology II, Leibniz-Institut für Molekulare Pharmakologie (FMP) |
|
4.45 pm |
Multimerization Technologies for Biologics and Toxins Michael Joachim Sefkow, Celares GmbH |
|
5.10 pm |
CCMS: Case Study to differentiate COMT inhibitors with respect to their off-target interactions Mathias Dreger, Head of Biochemistry & Bioanalytics, caprotec bioanalytics GmbH |
|
5.35 pm |
Kinetic analysis of protein stability reveals age-dependent degradation Matthias Selbach, Max Delbrück Center for Molecular Medicine in the Helmholtz Association |
|
6.00 pm |
Get-together with Poster Presentation |
Please register http://www.healthcapital.de/nc/artikel/details/dechema-satellite-meeting-2016/
Venue: Max Delbrück Communications Center (MDC.C) C83, Axon 2, Campus Berlin-Buch, Robert-Rössle-Straße 10, 13125 Berlin
Please find Russ Hodge's Science blog with more cartoons here http://www.goodsciencewriting.wordpress.com